Antibiotic resistance of enteropathogenic bacteria in a teaching hospital in North Khuzestan during a three-year period.

Behnaz Deihim, Parisa Masoudipour
Author Information
  1. Behnaz Deihim: Infectious and Tropical Diseases Research Center, Dezful University of Medical Sciences, Dezful, Iran.
  2. Parisa Masoudipour: Department of Microbiology, Tertiary Ganjavian Hospital, Dezful University of Medical Sciences, Dezful, Iran.

Abstract

Introduction: Gastrointestinal infections affect many people annually. The most common bacterial agents involved in these infections are enteropathogenic bacteria and in the continuation of using broad-spectrum antibiotics, -associated diarrhea is involved, especially in hospitalized patients. The aim of the present study was to investigate the pattern of antibiotic resistance among enteropathogenic bacteria.
Materials and Methods: In this cross-sectional study, 163 samples of patients with diarrhea in Dezful Ganjavian Hospital were examined. The samples were cultured in MacConkey, Hektoen enteric agar and GN broth, and cycloserine cefoxitin fructose agar media and incubated under standard conditions. In order to identify enteropathogenic bacteria, biochemical tests and serological confirmatory tests were used. Antibiotic resistance pattern of the isolates was investigated by Kirby-Bauer disk diffusion susceptibility test.
Results: The frequency of pathogenic bacteria includes 41.1% of , followed by 41.1% of , 6.7% of Enteropathogenic , 5.5% of Serogroup B, and 5.5% of . The results revealed a total of 46 patients with orders regarding culture, no was isolated from the samples. The studied isolates showed the highest resistance to trimethoprim-sulfamethoxazole, and ceftriaxone (88.3%), and the most effective antibiotic in the treatment of patients was ciprofloxacin with 86% sensitivity.
Conclusion: Susceptibility to antibiotics was different among the isolates, which shows that the early identification of the infection agent and the selection of the correct antibiotic treatment are effective in improving the gastrointestinal infection and preventing the spread of the infection.

Keywords

References

  1. N Engl J Med. 2008 Oct 30;359(18):1932-40 [PMID: 18971494]
  2. Infect Control Hosp Epidemiol. 2008 Sep;29(9):887-9 [PMID: 18681812]
  3. BMC Gastroenterol. 2021 Mar 30;21(1):140 [PMID: 33784974]
  4. PLoS One. 2022 Nov 21;17(11):e0277574 [PMID: 36409683]
  5. J Clin Microbiol. 2008 Sep;46(9):3028-32 [PMID: 18650353]
  6. Inflamm Bowel Dis. 2013 Dec;19(13):2744-52 [PMID: 24145927]
  7. Proc Natl Acad Sci U S A. 2022 May 3;119(18):e2119396119 [PMID: 35476524]
  8. Epidemiol Infect. 1987 Oct;99(2):355-9 [PMID: 3315708]
  9. Nat Rev Microbiol. 2009 Jul;7(7):526-36 [PMID: 19528959]
  10. Trends Microbiol. 2016 Jun;24(6):463-476 [PMID: 26897710]
  11. Ann Clin Microbiol Antimicrob. 2018 Feb 1;17(1):1 [PMID: 29391040]
  12. Interdiscip Perspect Infect Dis. 2023 Sep 2;2023:8277976 [PMID: 37692062]
  13. Microb Drug Resist. 2017 Dec;23(8):1037-1044 [PMID: 29106325]
  14. Acta Microbiol Immunol Hung. 2012 Sep;59(3):367-74 [PMID: 22982640]
  15. Microb Pathog. 2017 Aug;109:45-48 [PMID: 28526638]
  16. Tech Coloproctol. 2014 Mar;18(3):223-32 [PMID: 24178946]
  17. World J Gastroenterol. 2010 Oct 21;16(39):4892-904 [PMID: 20954275]
  18. Can J Infect Dis Med Microbiol. 2009 Fall;20(3):e56-62 [PMID: 20808457]
  19. New Microbes New Infect. 2018 Aug 02;25:52-57 [PMID: 30094031]
  20. Trop Med Health. 2019 May 02;47:29 [PMID: 31073272]
  21. Am J Gastroenterol. 2009 May;104(5):1162-9 [PMID: 19319128]
  22. Emerg Infect Dis. 2022 Jun;28(6):1110-1116 [PMID: 35608550]
  23. MMWR Morb Mortal Wkly Rep. 2005 Dec 2;54(47):1201-5 [PMID: 16319813]
  24. Curr Opin Infect Dis. 2014 Oct;27(5):451-8 [PMID: 25101554]
  25. J Med Microbiol. 2014 Mar;63(Pt 3):427-432 [PMID: 24281909]
  26. Vet Microbiol. 2017 Feb;199:15-22 [PMID: 28110780]
  27. Inflamm Bowel Dis. 2008 Oct;14(10):1432-42 [PMID: 18484669]
  28. Emerg Microbes Infect. 2022 Dec;11(1):1982-1993 [PMID: 35880487]
  29. Int J Antimicrob Agents. 2013 Jan;41(1):80-4 [PMID: 23148985]
  30. Int J Antimicrob Agents. 2009 Dec;34(6):516-22 [PMID: 19828299]
  31. Infect Control Hosp Epidemiol. 2009 Jan;30(1):57-66 [PMID: 19049438]

Word Cloud

Created with Highcharts 10.0.0bacteriaresistanceenteropathogenicpatientsinfectionsantibioticsamplesAntibioticisolatesinfectioninvolvedantibioticsdiarrheastudypatternamongagartests411%55%effectivetreatmentgastrointestinalsppIntroduction:Gastrointestinalaffectmanypeopleannuallycommonbacterialagentscontinuationusingbroad-spectrum-associatedespeciallyhospitalizedaimpresentinvestigateMaterialsMethods:cross-sectional163DezfulGanjavianHospitalexaminedculturedMacConkeyHektoenentericGNbrothcycloserinecefoxitinfructosemediaincubatedstandardconditionsorderidentifybiochemicalserologicalconfirmatoryusedinvestigatedKirby-BauerdiskdiffusionsusceptibilitytestResults:frequencypathogenicincludesfollowed67%EnteropathogenicSerogroupBresultsrevealedtotal46ordersregardingcultureisolatedstudiedshowedhighesttrimethoprim-sulfamethoxazoleceftriaxone883%ciprofloxacin86%sensitivityConclusion:SusceptibilitydifferentshowsearlyidentificationagentselectioncorrectimprovingpreventingspreadteachinghospitalNorthKhuzestanthree-yearperiodClostridiumdifficileSalmonellaShigella

Similar Articles

Cited By

No available data.